Particle.news
Download on the App Store

Indecopi Fines Medifarma S/2.4 Million Over Defective 0.9% Saline, Orders Remedies

Investigators tied the defective lot to production failures under the company’s control.

Overview

  • Indecopi’s Consumer Protection Commission No. 3 issued the maximum penalty of 450 UIT (S/2,407,500) in a first-instance ruling.
  • The sanction followed findings that a 0.9% saline lot posed an unjustified risk to consumers, with at least 30 patients affected and four deaths recorded in the case file.
  • Medifarma must cover victims’ medical care, assume funeral costs where applicable, and implement a compliance program.
  • The resolution remains within the appeal window and, if contested, would move to Indecopi’s Specialized Consumer Protection Chamber for review.
  • Adverse events were first reported on March 21, 2025, and the commission found no objective or unforeseeable cause that would exempt the company from responsibility.